Filter By Industry
Filter By Tag


Immunodominant Press releases

1 - 1 of 1 Press Release

Nov 15, 2022
Immunodominant Inc., a drug discovery and development company engaged in progressing innovative research from academia to commercialization, today announced its intention to begin an initial financing round of up to $30 million.

Immunodominant RSS Feed